BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5985108)

  • 21. [The bacterial agents responsible for urinary tract infections. II: Study of variations in time of the sensitivity of the bacterial agents to various types of chemoantibiotics].
    Mendicino A; Calise R; Prosperi F; De Rossi P; Granato C; Lauretti MC; Naso C; Sonnino A; Roscioni C
    Clin Ter; 1983 Oct; 107(1):29-35. PubMed ID: 6653068
    [No Abstract]   [Full Text] [Related]  

  • 22. [Ribostamycin in chronic and recurrent bronchopulmonary and urinary infections].
    Abate G; Polimeni RM; Visani G
    Minerva Med; 1980 Feb; 71(4):279-85. PubMed ID: 7354947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Determination of antibacterial agents in urine as support of an effective drug therapy in urinary tract infections].
    Kiessig R
    Z Gesamte Hyg; 1982 Jun; 28(6):405-7. PubMed ID: 7124030
    [No Abstract]   [Full Text] [Related]  

  • 24. Management of urinary tract infections.
    Asscher AW
    Del Med J; 1981 Feb; 53(2):85-9. PubMed ID: 7202780
    [No Abstract]   [Full Text] [Related]  

  • 25. Cefotaxime in a single daily dose in lower urinary tract infections.
    Peralta S; Affronti M; Malta R; Delle Vedove G; Pirrotta P; Rotondo G; Paternostro D; Rini GB; Di Rosa S
    J Chemother; 1989 Jul; 1(4 Suppl):847-8. PubMed ID: 16312666
    [No Abstract]   [Full Text] [Related]  

  • 26. [Severe gram-negative urinary infections].
    Vittecoq D; Modai J
    Rev Prat; 1983 Jan; 33(3):113-6. PubMed ID: 6682571
    [No Abstract]   [Full Text] [Related]  

  • 27. Ofloxacin in the treatment of genito-urinary tract infections.
    Marone P; Concia E; Quarta V; Minoli L; Carnevale G
    J Chemother; 1989 Jul; 1(4 Suppl):854-5. PubMed ID: 16312670
    [No Abstract]   [Full Text] [Related]  

  • 28. [Adequate prescription of antibiotic therapy for urinary tract infections in hospital: identifying and correcting non-observance of guidelines].
    Arnaud I; Elkouri D; N'Guyen JM; Foucher Y; Karam G; Lepage JY; Billard M; Potel G; Lombrail P
    Med Mal Infect; 2005 Mar; 35(3):141-8. PubMed ID: 15911184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biotyping and susceptibility behaviour of pathogens in patients treated with ciprofloxacin.
    Krasemann C; Von Poppel H; Wegge M; Chysky V
    J Chemother; 1989 Jul; 1(4 Suppl):386-8. PubMed ID: 16312452
    [No Abstract]   [Full Text] [Related]  

  • 30. [Specificity of chemotherapy in urology].
    Okoshi M
    Saishin Igaku; 1969 Sep; 24(9):1869-73. PubMed ID: 5353797
    [No Abstract]   [Full Text] [Related]  

  • 31. [Personal experience with Binotal (R) in urology].
    Rief JA
    Hospital (Rio J); 1968 Jul; 74(1):79-85. PubMed ID: 5305568
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical trials of CB 80.53].
    Lapeyre L; Commandre F; Moulin M; Desplans J
    Mars Med; 1965; 102(4):343-8. PubMed ID: 5889146
    [No Abstract]   [Full Text] [Related]  

  • 33. [Infectiology of the urogenital tract. 4: Quality assurance--antibiotic selection in uncomplicated urinary tract infections].
    Naber KG
    Fortschr Med; 1997 May; 115(15):38-42. PubMed ID: 9289477
    [No Abstract]   [Full Text] [Related]  

  • 34. [Chronic urinary tract infections: diagnosis and treatment].
    Glauser MP
    Rev Med Suisse Romande; 1984 May; 104(5):395-400. PubMed ID: 6463483
    [No Abstract]   [Full Text] [Related]  

  • 35. [Antibiotic therapy by first intention].
    Bastin R
    Rev Prat; 1983 Oct; 33(45):2361-76. PubMed ID: 6648276
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation of the efficacy and safety of imipenem/cilastatin in the treatment of complicated urinary tract infections.
    Goldoni S; Gandolfi P; Tubaro A; Vicentini C; Lancione P; Miano L
    J Chemother; 1989 Jul; 1(4 Suppl):845-7. PubMed ID: 16312665
    [No Abstract]   [Full Text] [Related]  

  • 37. Effectiveness of low-dose daptomycin in the treatment of vancomycin-resistant enterococcal urinary tract infections.
    Fisher L; North D
    Int J Antimicrob Agents; 2009 May; 33(5):493-4. PubMed ID: 19153034
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of urinary tract infections in patients with risk factors].
    Núñez Sánchez JC; Catalá Barceló MT; Navarro Obrer I; Balaguer Martínez JV
    Med Clin (Barc); 1999 Sep; 113(8):319. PubMed ID: 10603588
    [No Abstract]   [Full Text] [Related]  

  • 39. Management of chronic urinary tract infection.
    Woo KT
    Singapore Med J; 1993 Jun; 34(3):193-7. PubMed ID: 8266169
    [No Abstract]   [Full Text] [Related]  

  • 40. Single-dose therapy of symptomatic urinary tract infections in women.
    Knight AL
    J Iowa Med Soc; 1982 Sep; 72(9):376-8. PubMed ID: 7175247
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.